Department of Pediatrics, Children's Mercy Kansas City and School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri;
School of Medicine, University of Kansas, Kansas City, Kansas.
Hosp Pediatr. 2020 Oct;10(10):851-858. doi: 10.1542/hpeds.2020-0114. Epub 2020 Sep 18.
Inflammatory marker testing in children has been identified as a potential area of overuse. We sought to describe variation in early inflammatory marker (C-reactive protein and erythrocyte sedimentation rate) testing for infection-related hospitalizations across children's hospitals and to determine its association with length of stay (LOS), 30-day readmission rate, and cost.
We conducted a cross-sectional study of children aged 0 to 17 years with infection-related hospitalizations using the Pediatric Health Information System. After adjusting for patient characteristics, we examined rates of inflammatory marker testing (C-reactive protein or erythrocyte sedimentation rate) during the first 2 days of hospitalization. We used k-means clustering to assign each hospital to 1 of 3 groups on the basis of similarities in adjusted diagnostic testing rates across 12 infectious conditions. Multivariable regression was used to examine the association between hospital testing group and outcomes.
We included 55 771 hospitalizations from 48 hospitals. In 7945 (14.3%), there was inflammatory marker testing in the first 2 days of hospitalization. We observed wide variation in inflammatory marker testing rates across hospitals and infections. Group A hospitals tended to perform more tests than group B or C hospitals (37.4% vs 18.0% vs 10.4%; < .001) and had the longest adjusted LOS (3.2 vs 2.9 vs 2.8 days; = .01). There was no significant difference in adjusted 30-day readmission rates or costs.
Inflammatory marker testing varied widely across hospitals. Hospitals with higher inflammatory testing for one infection tend to test more frequently for other infections and have longer LOS, suggesting opportunities for diagnostic stewardship.
在儿童中,炎症标志物检测已被确定为潜在的过度使用领域。我们旨在描述儿童医院中与感染相关的住院患者早期炎症标志物(C 反应蛋白和红细胞沉降率)检测的变异性,并确定其与住院时间(LOS)、30 天再入院率和成本的关系。
我们使用儿科健康信息系统对 0 至 17 岁的感染相关住院患儿进行了横断面研究。在调整患者特征后,我们检查了住院前 2 天内炎症标志物检测(C 反应蛋白或红细胞沉降率)的发生率。我们使用 K 均值聚类法,根据 12 种感染性疾病的调整诊断检测率相似性,将每家医院分配到 3 个组中的 1 个。多变量回归用于检查医院检测组与结果之间的关系。
我们纳入了来自 48 家医院的 55771 例住院患者。在 7945 例(14.3%)患者中,在住院前 2 天进行了炎症标志物检测。我们观察到医院和感染之间的炎症标志物检测率存在广泛差异。A 组医院的检测次数多于 B 组或 C 组医院(37.4%比 18.0%比 10.4%;<0.001),且调整后的 LOS 也最长(3.2 天比 2.9 天比 2.8 天;=0.01)。调整后的 30 天再入院率或成本无显著差异。
炎症标志物检测在医院之间差异很大。对一种感染进行更多炎症检测的医院往往会更频繁地检测其他感染,且 LOS 更长,这表明存在诊断管理的机会。